Quantcast
Last updated on April 17, 2014 at 9:25 EDT

Latest Meningococcal disease Stories

2014-02-26 08:28:23

DORVAL QC, Feb. 26, 2014 /CNW/ - Novartis announced today that Bexsero(®) (Multicomponent Meningococcal B Vaccine [recombinant, adsorbed]) is now available to doctors and pharmacists across Canada. The vaccine is approved for use in individuals from two months through 17 years of age in Canada. Infants, toddlers and adolescents are at the greatest risk of meningococcal serogroup B (MenB) infection.(1) Bexsero(®) is the first broad-coverage vaccine to help protect against MenB...

2014-02-24 08:28:29

- FDA granted special use of Bexsero for nearly 20,000 UCSB students and staff in response to outbreak; the vaccine is licensed in Europe, Australia and Canada CAMBRIDGE, Mass., Feb. 24, 2014 /PRNewswire/ -- Novartis announced today that its meningococcal serogroup B (MenB) vaccine, Bexsero(®) (Meningococcal Group B Vaccine [rDNA, component, adsorbed]), will be used as part of a vaccination program at the University of California Santa Barbara (UCSB) that began today and will end on March 7....

2014-02-09 04:20:17

LONDON, February 9, 2014 /PRNewswire/ -- INTERNATIONAL photographer and artist Anne Geddes invites us to take a fresh look at disability, with three new thought-provoking portraits of UK children who have lost limbs to meningitis. (Photo: http://photos.prnewswire.com/prnh/20140209/668113-a ) (Photo: http://photos.prnewswire.com/prnh/20140209/668113-b ) (Photo: http://photos.prnewswire.com/prnh/20140209/668113-c ) Amber Travers (5),...

2014-01-08 17:32:42

A special issue on sepsis has been released by the publisher Landes Bioscience (Austin, TX USA). The articles contained in this special issue of the journal Virulence have been authored by world-class investigators and provide new insights into both the pathogen-related factors and the host defense mechanisms that lead to septic shock and contribute to its resolution or fatal outcome. Sepsis, or septic shock, is an excessive inflammatory response in answer to a serious infection, most...

2013-12-26 08:23:12

LONDON, Dec. 26, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 SummaryMeningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these...

2013-12-26 08:23:10

LONDON, Dec. 26, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 SummaryMeningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons...

2013-12-26 08:23:07

LONDON, Dec. 26, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 SummaryMeningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the...

2013-12-19 16:27:31

LONDON, Dec. 19, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report:PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, "PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022". Meningococcal disease is an acute infection caused by the gram-negative...

2013-12-19 16:27:25

LONDON, Dec. 19, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report:PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, "PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022". Meningococcal disease is an acute infection caused by the gram-negative bacterium...

2013-12-12 20:25:03

BETHESDA, Md., Dec. 12, 2013 /PRNewswire/ -- According to a new report issued today by the National Foundation for Infectious Diseases and Pfizer Inc., adolescents are often overlooked in the US healthcare system, which may lead to short- and long-term health consequences and contribute to the economic burden on the healthcare system. The report, titled The Case for Improving Adolescent Health: Helping prepare adolescents for a healthy future, suggests that an annual preventive care...


Latest Meningococcal disease Reference Libraries

72_d0e074525de5bb741daf382f8d62213f
2011-04-25 16:38:12

Neisseria meningitidis is a heterotrophic gram-negative diplococcal bacterium best known for its role in meningitis and other forms of meningococcal disease such as meningococcemia. It is a major cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in Africa and in Asia. In the US there are approximately 2500 to 3500 cases of N. meningitides infections. Children under 5 are at a higher risk as well as people in the sub-Saharan...

More Articles (1 articles) »